Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Nolan

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
British Journal of Cancer|September 7, 2013
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkersA R Green, D G Powe, E A Rakha, et al.
Breast Cancer Research and Treatment|April 27, 2016
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
British Journal of Cancer|February 18, 2015
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy responseM M Al-Kaabi, A T Alshareeda, D A Jerjees, et al.
Breast Cancer Research and Treatment|July 31, 2012
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK womenA J Agboola, A A Musa, N Wanangwa, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
British Journal of Cancer|September 7, 2013
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkersA R Green, D G Powe, E A Rakha, et al.
Breast Cancer Research and Treatment|April 27, 2016
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
British Journal of Cancer|February 18, 2015
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy responseM M Al-Kaabi, A T Alshareeda, D A Jerjees, et al.
Breast Cancer Research and Treatment|July 31, 2012
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK womenA J Agboola, A A Musa, N Wanangwa, et al.
Pageof 4